Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2025Open Access

CK2.1 Activates Chondrogenesis in Chondrocytes from Osteoarthritis Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

KDKailey DeGeorgeVPVenu PanditDHDaniel Halloran

Discussion

Loading...

Member takes

Overview

Research demonstrates ck2.1 improves proteoglycan synthesis in chondrocytes, suggesting a novel treatment for osteoarthritis.

Key Points

  • CK2.1 significantly boosts chondrogenesis in chondrocytes from osteoarthritis patients.
  • The study utilized micromass cultures derived from chondrocytes isolated from human OA patients.
  • Results showed enhanced proteoglycan synthesis in treated chondrocytes, indicating effective action.
  • CK2.1 presents potential as a new therapeutic strategy for addressing osteoarthritis damage.

Cite This Study

DeGeorge et al. (2025) studied this question.

synapsesocial.com/papers/689a0c65e6551bb0af8cfbcdhttps://doi.org/10.20944/preprints202507.2612.v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effects of a Novel Mammalian-Derived Collagen Matrix on Human Articular Cartilage-Derived Chondrocytes from Osteoarthritis Patients2025 · 1 citations
  2. 2Pathophysiological Insights Into the Role of Osteoclasts in Osteoarthritis: Mechanisms, Therapeutic Targets, and Future Directions2025
  3. 3A NASAL CHONDROCYTE-BASED INFLAMMATION-RESISTANT THERAPY APPROACH FOR OSTEOARTHRITIS2025
  4. 4DEVELOPING A CARTILAGE-ON-CHIP PLATFORM FOR OSTEOARTHRITIS2025
  5. 5A novel peptide primes mesenchymal stem cell-derived extracellular vesicles to suppress osteoarthritis by promoting SOX9 and Collagen Type II expression 22472025